FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Drug Approved for Rare Forms of Obesity

[ Price : $8.95]

FDA approves a Rhythm Pharmaceutical NDA for Imcivree (setmelanotide) for chronic weight management in patients six years and olde...

Pilot Program for Novel Drug Development Tools

[ Price : $8.95]

FDA launches the Innovative Science and Technology Approaches for New Drugs pilot program for novel drug development tool develope...

Moderna Submits EUA for Covid-19

[ Price : $8.95]

Moderna submits an emergency use authorization for its Covid-19 vaccine mRNA-1273 based on updated efficacy data showing 94.1% vac...

Profound Medical HDE OKd for Osteoid Osteomas

[ Price : $8.95]

FDA approves a Profound Medical humanitarian device exemption to market Sonalleve for treating osteoid osteoma, a non-cancerous bo...

Former Insys President Debarred by FDA

[ Price : $8.95]

Federal Register notice: FDA orders the permanent debarment of Michael L. Babich from providing services in any capacity to a pers...

FDA Wants More CMC Info for Liquidia LIQ861

[ Price : $8.95]

An FDA complete response letter tells Liquidia the agency needs more CMC data on the companys LIQ861 inhalation powder to treat pu...

Guide on Drug Development Qualification Tools

[ Price : $8.95]

Federal Register notice: FDA posts a final guidance on its drug development tool qualification process.

Guide on Complex ANDA Product Meetings

[ Price : $8.95]

Federal Register notice: FDA makes available a final guidance entitled Formal Meetings Between FDA and ANDA Applicants of Complex ...

Notifying CDRH About Device Shortage Guidance Update

[ Price : $8.95]

FDA updates a CDRH Covid-19 guidance on notifying the agency of medical device discontinuance or shortages.

Use 510(k) for OTC Hearing Aids: Authors

[ Price : $8.95]

Two hospital-based doctors call on FDA to clear OTC hearing aids using the 510(k) pathway.